Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene nail lacquer for nail psoriasis
2004-004825-87Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tazarotene in nail psoriasis (4 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Expert Physician Global Assessment (EPGA) from photographs at 6 months. Started Feb 2005; status: completed.
02
Drugs
tazarotene
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on 2004-004825-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004825-87.